Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Psychosocial Study

Quality of life and social integration after allogeneic hematopoietic SCT

Abstract

In total, 124 adult patients in remission after allogeneic hematopoietic SCT (HSCT) participated in a cross-sectional study to assess health-related quality of life (HRQL). Assessment of HRQL was carried out using two questionnaires: the (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy (FACT) with specific modules for BMT (FACT-BMT). Transplanted patients differed from healthy controls in many HRQL-related dimensions in the EORTC QLQ-C30: social functioning 73.4 versus 85.8, P<0.0001; role functioning 74.6 versus 83.3, P<0.004; physical functioning 83.9 versus 89.9, P<0.001; emotional functioning 72.2 versus 82.8, P<0.0001 but were not significant for global HRQL 71.2 versus 75.3, P<0.03. In total, 60% of the patients returned to work after HSCT; 31% part time and 29% full time. Age at HSCT and employment status were significantly associated with HRQL. Other factors such as disease and disease stage and especially the occurrence of late complications did not impact the perception of HRQL. This study suggests that the perception of HRQL after HSCT differs from the general population. Issues to increase work-related capabilities and improve social support need to be addressed.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 2005; 23: 599–608.

    Article  PubMed  Google Scholar 

  2. Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T . Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol 2001; 80: 137–143.

    Article  CAS  PubMed  Google Scholar 

  3. Kopp M, Holzner B, Meraner V, Sperner-Unterweger B, Kemmler G, Nguyen-Van-Tam DP et al. Quality of life in adult hematopoietic cell transplant patients at least 5 years after treatment: a comparison with healthy controls. Eur J Haematol 2005; 74: 97–103.

    Article  Google Scholar 

  4. Baker F, Wingard JR, Curbow B, Zabora J, Jodrey D, Fogarty L et al. Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant 1994; 13: 589–596.

    CAS  PubMed  Google Scholar 

  5. Sutherland HJ, Fyles GM, Adams G, Hao Y, Lipton JH, Minden MD et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997; 19: 1129–1136.

    Article  CAS  PubMed  Google Scholar 

  6. Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM . Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993; 11: 319–327.

    CAS  PubMed  Google Scholar 

  7. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004; 291: 2335–2343.

    Article  CAS  PubMed  Google Scholar 

  8. Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW et al. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. Eur J Haematol 2000; 65: 97–103.

    Article  CAS  PubMed  Google Scholar 

  9. McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357–368.

    Article  CAS  PubMed  Google Scholar 

  10. Miralbell R, Rouzaud M, Grob E, Nouet P, Bieri S, Majno SB et al. Can a total body irradiation technique be fast and reproducible? Int J Radiat Oncol Biol Phys 1994; 29: 1167–1173.

    Article  CAS  PubMed  Google Scholar 

  11. Bieri S, Helg C, Chapuis B, Miralbell R . Total-body irradiation before allogeneic bone marrow transplantation: is more dose better? Int J Radiat Oncol Biol Phys 2001; 49: 1071–1077.

    Article  CAS  PubMed  Google Scholar 

  12. Miralbell R, Bieri S, Mermillod B, Helg C, Sancho G, Pastoors B et al. Renal toxicity after allogeneic bone marrow transplant: the combined effects of total body irradiation and graft versus host disease. J Clin Oncol 1996; 14: 579–585.

    Article  CAS  PubMed  Google Scholar 

  13. Chalandon Y, Roosnek E, Mermillod B, Waelchli L, Helg C, Chapuis B . Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus leukemia reaction? A prospective phase II study. Biol Blood Marrow Transplant 2006; 12: 102–110.

    Article  PubMed  Google Scholar 

  14. Hale G, Zhang MJ, Bunjes D, Prentice HG, Spence D, Horowitz MM et al. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. Blood 1998; 92: 4581–4590.

    CAS  PubMed  Google Scholar 

  15. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  PubMed  Google Scholar 

  16. Mor V, Laliberte L, Morris JN, Wiemann M . The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 1984; 53: 2002–2007.

    Article  CAS  PubMed  Google Scholar 

  17. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.

    Article  CAS  PubMed  Google Scholar 

  18. Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S . Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: The QLQ-C30 (+3). J Clin Oncol 1998; 16: 1188–1196.

    Article  CAS  PubMed  Google Scholar 

  19. Cella D . Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. Centre on Outcomes, Research and Education (CORE). Northwestern Healthcare and Northwestern University: Evanston, 1997.

    Google Scholar 

  20. Holzner B, Kemmler G, Cella D, De Paoli C, Meraner V, Kopp M et al. Normative data for Functional Assessment of Cancer Therapy. Acta Oncologica 2004; 43: 153–160.

    Article  PubMed  Google Scholar 

  21. Cox Dr, Snell EJ . The Analysis of Binary Data, 2nd edn. Chapman & Hall: London, 1989.

    Google Scholar 

  22. Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T . Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant 2001; 28: 503–509.

    Article  CAS  PubMed  Google Scholar 

  23. Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematology 2000; 110: 614–619.

    Article  CAS  Google Scholar 

  24. Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM . Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant 2000; 6: 576–591.

    Article  CAS  PubMed  Google Scholar 

  25. Wingard JR, Curbow B, Baker F, Piantadosi S . Health, functional status, and employment of adult survivors of bone marrow transplantation. Ann Intern Med 1991; 114: 113–118.

    Article  CAS  PubMed  Google Scholar 

  26. Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW et al. Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment. Ann Hematol 1998; 77: 27–32.

    Article  CAS  PubMed  Google Scholar 

  27. Barofsky I (ed). Work: issues and concepts. In: Work and Illness: the Cancer Patient. Praeger: New York, 1989, pp 3–24.

    Google Scholar 

Download references

Acknowledgements

We thank Professor M Kopp for his review and critical comments on the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y Chalandon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bieri, S., Roosnek, E., Helg, C. et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 42, 819–827 (2008). https://doi.org/10.1038/bmt.2008.253

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.253

Keywords

This article is cited by

Search

Quick links